COMPANY PROFILE / #3021
DeepLife
Vernon, FranceVenture Capital-Backed
OVERVIEW
Developer of a learning-powered platform designed to accelerate cell engineering and target identification in biotech and pharmaceutical research. The company offers a software-as-a-service platform that integrates multi-omics sequencing data, cell atlases, and proprietary deep learning tools, enabling researchers to simulate cell behavior in silico, identify molecular triggers, and optimize cell engineering processes efficiently.
已融资11.79
最新估值40.90
员工数25
成立年份2019
公司概况
- Companies
- DeepLife
- Description
- Developer of a learning-powered platform designed to accelerate cell engineering and target identification in biotech and pharmaceutical research. The company offers a software-as-a-service platform that integrates multi-omics sequencing data, cell atlases, and proprietary deep learning tools, enabling researchers to simulate cell behavior in silico, identify molecular triggers, and optimize cell engineering processes efficiently.
- Website
- www.deeplife.co
- HQ Location
- Vernon, France
- Year Founded
- 2019
- Keywords
- biotech company, biotech company operator, biotech service, drug discovery system, drug discovery tech, drug discovery technology, pharmaceutical data, pharmaceutical firm
- Competitors
- —
- Ownership Status
- Privately Held (backing)
- Company Financing Status
- Venture Capital-Backed
融资与估值
- Total Raised
- 11.79
- First Financing Date
- —
- First Financing Size
- —
- First Financing Valuation
- —
- Last Financing Date
- 11-Dec-2024
- Last Financing Deal Type
- Later Stage VC
- Last Financing Size
- 9.94
- Last Financing Valuation
- 40.90
- Last Financing Status
- Completed
- Last Known Valuation
- 40.90
- Last Known Valuation Date
- 11-Dec-2024
- Last Known Valuation Deal Type
- Later Stage VC
- Valuation Estimate
- 64.20
- Valuation Estimate Growth Rate
- 56.98%
- Active Investors
- Aloe Private Equity, Beiersdorf, Beiersdorf Venture Capital, Creative Destruction Lab, Entrepreneurs First, Future4care, Groupe Prunay, Kima Ventures, Mid Atlantic Bio Angels, Paris Biotech Sante, Pegase Capital, Relyens, Turenne Groupe, Unicorn Factory Lisboa, YZR Capital
- # Active Investors
- 15
- Acquirers
- —
团队与联系人
- Employees
- 25
- Employee Growth %
- -7.41%
- Employee History
- 2026: 25, 2025: 27, 2024: 26, 2023: 18 E, 2022: 10, 2021: 9
- Primary Contact
- Jonathan Baptista
- Primary Contact Title
- Co-Founder, Chief Executive Officer, and President
- Primary Contact Email
- jonathan.baptista@deeplife.co
- Primary Contact Phone
- +33 (0)7 68 80 96 52
增长与经营
- Revenue
- —
- Revenue Growth %
- —
- Growth Rate
- -0.71%
- Growth Rate % Change
- —
- Growth Rate Percentile
- 5
- Size Multiple
- 3.93x
- Size Multiple % Change
- 0.00%
- Size Multiple Change
- 0.00x
- Size Multiple Percentile
- 78
- Majestic Referring Domains
- 213
- SimilarWeb Unique Visitors
- 153
- SimilarWeb Unique Visitors Change
- -10
- SimilarWeb Growth Rate
- 0.00%
- SimilarWeb Growth Rate Percentile
- 9
- Success Probability Over Time – 1 Year
- 5%
- Success Probability Over Time – 3 Year
- 12%
- Success Probability Over Time – 5 Year
- 24%
记录来源：public.companies · 原始序号 #3021 · 所有字段均按数据库原值展示。